NTRK1 and neoplasm: Lar@NP‐OMVs treatment significantly inhibited neurite outgrowth by disrupting the neurotrophin/Trk signaling pathway and inducing M2‐like TAM‐mediated nerve injury, thereby suppressing neural‐induced tumor proliferation, migration, and angiogenesis, and enhancing chemotherapy efficacy in pancreatic cancer [209].